{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:13:56Z","timestamp":1783714436293,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.seminoncol.2025.152439","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:50:36Z","timestamp":1762617036000},"page":"152439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["UBE2T promotes papillary thyroid carcinoma progression by activating the JAK\/STAT3 pathway via negative regulation of SOCS2"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0617-3939","authenticated-orcid":false,"given":"Lijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houchao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heda","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca: Ca J Clin"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0002","article-title":"Cancer incidence and mortality in china, 2022","author":"Han","year":"2024","journal-title":"J Natl Ca Center"},{"issue":"35","key":"10.1016\/j.seminoncol.2025.152439_bib0003","doi-asserted-by":"crossref","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","article-title":"Tert accelerates braf mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis","volume":"9","author":"Yu","year":"2023","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152439_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cen.13413","article-title":"Prognostic implication of braf and tert promoter mutation combination in papillary thyroid carcinoma-a meta-analysis","volume":"87","author":"Vuong","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0005","doi-asserted-by":"crossref","first-page":"e8454","DOI":"10.7717\/peerj.8454","article-title":"The diagnostic and prognostic value of ube2t in intrahepatic cholangiocarcinoma","volume":"8","author":"Yu","year":"2020","journal-title":"Peerj"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0006","article-title":"Ubiquitin-conjugating enzyme e2t confers chemoresistance of colorectal cancer by enhancing the signal propagation of wnt\/beta-catenin pathway in an erk-dependent manner","author":"Liu","year":"2024","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.632531","article-title":"Ube2t contributes to the prognosis of esophageal squamous cell carcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0008","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12967-021-03056-1","article-title":"Ube2t promotes autophagy via the p53\/ampk\/mtor signaling pathway in lung adenocarcinoma","volume":"19","author":"Zhu","year":"2021","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152439_bib0009","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","article-title":"Targeting ube2t potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress","volume":"164","author":"Jiang","year":"2023","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152439_bib0010","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"Map kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The myc oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152439_bib0013","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The mapk signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the pi3k\/akt\/mtor signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the pi3k\/akt\/mtor signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152439_bib0016","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152439_bib0017","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the il-6\/jak\/stat3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting stat3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2017.06.001","article-title":"The jak\/stat3 axis: a comprehensive drug target for solid malignancies","volume":"45","author":"Huynh","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010217","article-title":"Role of jak\/stat3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0021","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41420-022-00922-9","article-title":"Inhibition of stat3(y705) phosphorylation by stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells","volume":"8","author":"Guo","year":"2022","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12929-020-00697-0","article-title":"Circnol10 suppresses breast cancer progression by sponging mir-767-5p to regulate socs2\/jak\/stat signaling","volume":"28","author":"Wang","year":"2021","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.seminoncol.2025.152439_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271102","article-title":"Socs-jak-stat inhibitors and socs mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis","volume":"14","author":"Pandey","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152439_bib0024","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the jak\/stat pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci"},{"issue":"22","key":"10.1016\/j.seminoncol.2025.152439_bib0025","article-title":"Smoking-induced m2-tams, via circeml4 in evs, promote the progression of nsclc through alkbh5-regulated m6a modification of socs2 in nsclc cells","volume":"10","author":"Cheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152439_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","article-title":"Socs2-enhanced ubiquitination of slc7a11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152439_bib0027","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"Rna n6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through ythdf2-dependent posttranscriptional silencing of socs2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152439_bib0028","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bjc.2014.377","article-title":"Identification of socs2 and socs6 as biomarkers in human colorectal cancer","volume":"111","author":"Letellier","year":"2014","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.seminoncol.2025.152439_bib0029","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/0008-5472.CAN-23-0337","article-title":"Hypoxia-responsive lncrna ac115619 encodes a micropeptide that suppresses m6a modifications and hepatocellular carcinoma progression","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:31:02Z","timestamp":1783711862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0093775425001319"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152439","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UBE2T promotes papillary thyroid carcinoma progression by activating the JAK\/STAT3 pathway via negative regulation of SOCS2","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152439"}}